Arasu Ganesan on Personalised Medicine

Interviewed at the COST conference on Personalised Medicine, Arasu Ganesan, Professor, University of East Anglia comments on how drug design and development need adapting to new knowledge in epigenetics.
COST - European Cooperation in Science and Technology - organised the 'Personalised Medicine: Better Healthcare for the Future' event from 17 to 22 June 2012 in Cyprus to bring together researchers, scientists, policy-makers, patients' associations and stakeholders to widen conceptions of personalised medicine and provide education about new developments in the field.
For more information on the conference including presentations, please visit www.cost.eu/events/pemed
Interview: Sheryl Torr-Brown